Required concentration index quantifies effective drug combinations against hepatitis C virus infection

Successful clinical drug development requires rational design of combination treatments based on preclinical data. Anti-hepatitis C virus (HCV) drugs exhibit significant diversity in antiviral effect. Dose-response assessments can be used to determine parameters profiling the diverse antiviral effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakizoe, Yusuke, Koizumi, Yoshiki, Ikoma, Yukino, Ohashi, Hirofumi, Wakita, Takaji, Iwami, Shingo, Watashi, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796629/
https://www.ncbi.nlm.nih.gov/pubmed/33422060
http://dx.doi.org/10.1186/s12976-020-00135-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796629/
https://www.ncbi.nlm.nih.gov/pubmed/33422060
http://dx.doi.org/10.1186/s12976-020-00135-6

Ejemplares similares